Vor Bio to Participate in Upcoming Investor Conferences
25 9월 2023 - 9:00PM
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering
company, today announced that it will participate in the following
upcoming investor conferences:
Chardan’s 7th Annual
Genetic Medicines ConferenceFireside Chat: Monday, October
2, 2023 at 4:00 pm ET Location: The Westin New York Grand Central,
New York, NY
A live webcast and archived replay of the fireside chat will be
available on the investors section of www.vorbio.com.
JonesTrading 2023 Healthcare SummitOctober
10-11, 2023Location: Eden Rock Miami Beach, Miami, FL
About Vor BioVor Bio is a clinical-stage cell
and genome engineering company that aims to change the standard of
care for patients with blood cancers by engineering hematopoietic
stem cells to enable targeted therapies post-transplant. For more
information, visit: www.vorbio.com.
Contact:
Media & InvestorsSarah Spencer +1
857-242-6076sspencer@vorbio.com
Vor Biopharma (NASDAQ:VOR)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Vor Biopharma (NASDAQ:VOR)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
